ES2044561T3 - Composiciones liquidas administrables por via oral a base de aceites comestibles. - Google Patents

Composiciones liquidas administrables por via oral a base de aceites comestibles.

Info

Publication number
ES2044561T3
ES2044561T3 ES90902945T ES90902945T ES2044561T3 ES 2044561 T3 ES2044561 T3 ES 2044561T3 ES 90902945 T ES90902945 T ES 90902945T ES 90902945 T ES90902945 T ES 90902945T ES 2044561 T3 ES2044561 T3 ES 2044561T3
Authority
ES
Spain
Prior art keywords
originally
liquid compositions
compositions based
edible oils
administrable liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902945T
Other languages
English (en)
Inventor
Leonard Chavkin
Leonard Mackles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2044561T3 publication Critical patent/ES2044561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTAN COMPUESTOS LIQUIDOS ORALMENTE ADMINISTRABLES PARA SUSPENDER EN LOS MISMOS COMPUESTOS FARMACOLOGICAMENTE ACTIVOS Y ORALMENTE ADMINISTRABLES QUE COMPRENDEN TRIGLICERIDOS, ESTERGLICOL DE PROPILENO O GLICERIDOS MONOACETILADOS DE ACIDOS ALCANOICOS DE LONGITUD MEDIA DE CADENA , ESTERES DE POLIGLICEROL, Y DIOXIDO DE SILICIO COLOIDAL.
ES90902945T 1989-01-03 1990-01-02 Composiciones liquidas administrables por via oral a base de aceites comestibles. Expired - Lifetime ES2044561T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/293,194 US4980175A (en) 1989-01-03 1989-01-03 Liquid orally administrable compositions based on edible oils

Publications (1)

Publication Number Publication Date
ES2044561T3 true ES2044561T3 (es) 1994-01-01

Family

ID=23128090

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902945T Expired - Lifetime ES2044561T3 (es) 1989-01-03 1990-01-02 Composiciones liquidas administrables por via oral a base de aceites comestibles.

Country Status (8)

Country Link
US (1) US4980175A (es)
EP (1) EP0452416B1 (es)
JP (1) JPH04502623A (es)
AU (1) AU5045490A (es)
CA (1) CA2045488A1 (es)
DE (1) DE69002611T2 (es)
ES (1) ES2044561T3 (es)
WO (1) WO1990007343A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
CH682131A5 (es) * 1991-04-25 1993-07-30 Applied Pharma Res
US5164379A (en) * 1991-07-15 1992-11-17 Bristol-Myers Company Sucralfate/cyclodextrin complexes
DE9212938U1 (de) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim Calciumpolycarbophil-Zubereitung zur Einnahme hoher Wirkstoffdosen
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
US6066342A (en) * 1995-12-22 2000-05-23 Tamer International, Ltd. Antacid composition
US5853787A (en) * 1995-12-22 1998-12-29 Tamer International Method for reducing coffee acidity
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
WO2012020279A1 (en) * 2010-08-13 2012-02-16 Compagnie Gervais Danone Product for the upper gastric sphere
KR20140057604A (ko) * 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2013129944A1 (en) 2012-02-27 2013-09-06 Bayer New Zealand Limited Controlled release compositions and their methods of use
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL261496A (es) * 1960-02-26
US2988483A (en) * 1960-10-19 1961-06-13 Drew & Co Inc E F Alchol soluble glycerides
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1547164A (en) * 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4639367A (en) * 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
US4889709A (en) * 1985-03-18 1989-12-26 Product Resources International, Inc. Aerosol foam with adsorbate and container containing same
US4752465A (en) * 1985-09-20 1988-06-21 Product Resources International, Inc. Aerosol foam
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
JPS62186936A (ja) * 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物

Also Published As

Publication number Publication date
CA2045488A1 (en) 1990-07-04
DE69002611T2 (de) 1994-02-03
JPH04502623A (ja) 1992-05-14
US4980175A (en) 1990-12-25
AU5045490A (en) 1990-08-01
WO1990007343A1 (en) 1990-07-12
EP0452416A1 (en) 1991-10-23
EP0452416B1 (en) 1993-08-04
DE69002611D1 (de) 1993-09-09

Similar Documents

Publication Publication Date Title
HRP20010615B1 (hr) Farmaceutski pripravak koji sadržava inhibitore protonske pumpe
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES2016585B3 (es) Polibutilaminas y poliisobutilaminas, procedimiento para su preparacion y composiciones combustibles y lubricantes que contienen estas sustancias.
PT83872A (de) Arzneimittel
DE3869444D1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
AR008630A1 (es) Indol-3-glioxilamidas n-sustituidas con efecto antiasmatico, antialergico e inmunosupresor/inmunomodulador, procedimientos para su preparacion, suutilizacion farmaceutica y las composiciones farmaceuticas que las contienen.
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
ES2145545T3 (es) Medicamentos que fomentan la circulacion sanguinea gastrointestinal.
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2012809B3 (es) Derivados del taxol, su preparacion y composiciones farmaceuticas que los contienen.
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
DE3763582D1 (de) Diltiazem und einen inhibitor des umwandlungsenzyms des angiotensins enthaltende arzneimittel.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
MX9301157A (es) Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR002759A1 (es) Composiciones farmaceuticas en dosis unitarias, que incluyen inhibidores de proteinasa.
IT8722641A0 (it) Piedino abbattibile per mobili.
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
FI874450A0 (fi) Farmaceutiska sammansaettningar vid terapin av hjaernsjukdomar pao funktionell och organisk bas.
SE8003850L (sv) Plasmaexpanderande medel
ATE92324T1 (de) Orale zubereitungsform des oestradiolvalerats.
ES2106922T3 (es) 3-beta-derivados de digitoxigenina y dihidrodigitoxigenina y composiciones farmaceuticas que los contienen para el tratamiento de la hipertension.
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 452416

Country of ref document: ES